Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Forecast for the Nocturia Market from 2024 to 2025?
Over the past few years, the nocturia market has witnessed substantial growth. The market value is projected to surge from $2.87 billion in 2024 to $3.11 billion in 2025, with a compound annual growth rate (CAGR) of 8.4%. A rise in cardiovascular ailments, growing instances of insomnia, an increase in the senior population, heightened understanding of nocturia and related conditions, and the growth in comorbidities have collectively contributed to the expansion during the historic period.
What Is the Projected Market Size of the Nocturia Market?
The market size of nocturia is anticipated to experience robust growth in the forthcoming years, expanding to $4.23 billion by 2029 at a Compound Annual Growth Rate (CAGR) of 8.0%. This rise during the projected period can be credited to the escalating incidences of disorders involving bladder obstruction and inflammation in urinary tracts, along with an increasing occurrence of nocturia due to various risk factors such as excessive nighttime urination. High fluid consumption contributing to nocturia, growing knowledge regarding the link between nocturia and sleep disorders or kidney health, as well as an aging population, are all contributing to this growth. Notable trends during the forecasted period comprise improvements in diagnostic techniques, the creation of novel drugs, amplified research and investment into treatments for nocturia, advancements in surgical and non-surgical treatments, and the acceptance of personalized medicine.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21232&type=smp
Who are the Major Competitors in the Nocturia Market Outlook?
Major companies operating in the nocturia market are Pfizer Inc, Merck & Co. Inc, AbbVie Inc, Sanofi S.A, GlaxoSmithKline plc, Viatris Inc, Boehringer Ingelheim International GmbH, Otsuka Pharmaceutical Co. Ltd, Astellas Pharma Inc, Eisai Co. Ltd., Sumitomo Dainippon Pharma Co. Ltd, Ferring Pharmaceuticals A/S, Avadel Pharmaceuticals plc, UroGen Pharma Ltd, Sanwa Kagaku Co. Ltd., Urovant Sciences Inc, Serenity Pharmaceuticals LLC, Vantia Therapeutics Inc, AA Pharma Inc, Wellesley Pharmaceuticals Inc
What Is Fueling Growth in the Nocturia Market?
As cardiovascular diseases continue to surge, their role in driving the growth of the nocturia market is expected to increase. These diseases, encompassing conditions like heart disease, stroke, and hypertension, affect heart and blood vessels. The mounting prevalence of cardiovascular diseases can be linked to factors such as sedentary lifestyles, aging demographics, unhealthy eating habits, smoking, excessive intake of alcohol, obesity, elevated blood pressure, high cholesterol levels, diabetes, and genetic susceptibility. These ailments often trigger nocturia symptoms in patients, thereby ramping up demand for diagnostics and treatments. The global rise in cardiovascular conditions, fueled by aging populations and unhealthy lifestyles, underlines the growing necessity for managing nocturia effectively. For instance, the Centers for Disease Control and Prevention, a US governmental agency, reported in May 2024 that cardiovascular disease led to 702,880 deaths, making up 20% of all deaths in the US in 2022. Each year, around 805,000 individuals suffer a heart attack, including 605,000 first-time occurrences and 200,000 in those with prior occurrences. Therefore, escalating prevalence of cardiovascular diseases augments the growth of the nocturia market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=21232&type=smp
Which Nocturia Market Segments Are Growing the Fastest?
The nocturia market covered in this report is segmented –
1) By Drug: Anticholinergic Drugs, Desmopressin, Antibiotics, Antispasmodic, Other Drugs
2) By Indication: Mixed Nocturia, Low Nocturnal Bladder Capacity, Nocturnal Polyuria, Global Polyuria
3) By Causes: Urological Infection, Tumor Of The bladder, Diuretic Medications, Regular Alcohol Or coffee, Liver infection, Diabetes, Pregnancy, Other Causes
4) By End User: Hospitals, Home Care, Clinics
Subsegments:
1) By Anticholinergic Drugs: Oxybutynin, Tolterodine, Solifenacin, Darifenacin, Fesoterodine
2) By Desmopressin: Intranasal Desmopressin, Oral Desmopressin
3) By Antibiotics: Nitrofurantoin, Trimethoprim, Fosfomycin, Other Antibiotics
4) By Antispasmodic: Hyoscine Butylbromide, Flavoxate, Other Antispasmodics
5) By Other Drugs: Alpha-blockers, Beta-3 Agonists, Diuretics, Other Pharmacological Treatments
Which Industry Trends Are Shaping the Future of the Nocturia Market?
Significant players in the nocturia market are working on producing unique products like orally disintegrating tablets (ODTs) to improve patient comfort and adherence. ODTs, which are solid drugs that rapidly dissolve in the mouth without requiring water, are particularly optimal for patients struggling with swallowing. In July 2024, Adalvo Limited, a pharmaceutical enterprise based in Malta, introduced Desmopressin ODT to the European market. This drug is used to treat conditions that lead to excessive fluid loss from the body, including central cranial diabetes insipidus. It is a synthetic version of vasopressin and effectively controls diabetes insipidus, extreme thirst and urination, and bedwetting by imitating the function of the natural hormone and reducing the volume of water expelled with urine. Additionally, it can regulate bleeding in mild to moderate cases of hemophilia A and von Willebrand disease by accelerating the release of elements that help blood clot.
Access The Full Report Here:
https://www.thebusinessresearchcompany.com/report/nocturia-global-market-report
Which Countries Are Leading the Nocturia Market?
North America was the largest region in the nocturia market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nocturia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21232
This Report Delivers Insight On:
1. How big is the nocturia market, and how is it changing globally?
2. Who are the major companies in the nocturia market, and how are they performing?
3. What are the key opportunities and risks in the nocturia market right now?
4. Which products or customer segments are growing the most in the nocturia market?
5. What factors are helping or slowing down the growth of the nocturia market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model